Preferably Pharm.D, M.Pharm with Experience in Coordinating and conducting clinical trials. Clinical Research project A Phase II, Multi-center, Singlearm, Open-label Study to Assess the Efficacy and Safety of Tenalisib, a PI3K 5/y and SIK3 Inhibitor, in patients with Metastatic Triple Negative Breast Cancer.